How Do You Treat Chronic Anxiety in Your Practice?

2021 ◽  
Vol 33 (6) ◽  
pp. 447-449
Keyword(s):  
Chronic Anxiety

scholarly journals Health and Illness as Enacted Phenomena

Topoi ◽  
2021 ◽  
Author(s):  
Fredrik Svenaeus
Keyword(s):  
Good Life ◽  
Point Of View ◽  
The Other ◽  
Lived Body ◽  
Existential Feelings ◽  
Other Hand ◽  
Health And Illness ◽  
Chronic Anxiety ◽  
Phenomenological View ◽  
Life Projects

AbstractIn this paper I explore health and illness through the lens of enactivism, which is understood and developed as a bodily-based worldly-engaged phenomenology. Various health theories – biomedical, ability-based, biopsychosocial – are introduced and scrutinized from the point of view of enactivism and phenomenology. Health is ultimately argued to consist in a central world-disclosing aspect of what is called existential feelings, experienced by way of transparency and ease in carrying out important life projects. Health, in such a phenomenologically enacted understanding, is an important and in many cases necessary part of leading a good life. Illness, on the other hand, by such a phenomenological view, consist in finding oneself at mercy of unhomelike existential feelings, such as bodily pains, nausea, extreme unmotivated tiredness, depression, chronic anxiety and delusion, which make it harder and, in some cases, impossible to flourish. In illness suffering the lived body hurts, resists, or, in other ways, alienates the activities of the ill person.

Role of stress, corticotrophin releasing factor (CRF) and amygdala plasticity in chronic anxiety

Stress ◽  
2005 ◽  
Vol 8 (4) ◽  
pp. 209-219 ◽  
Author(s):  
Anantha Shekhar ◽  
William Truitt ◽  
Donald Rainnie ◽  
Tammy Sajdyk
Keyword(s):  
Corticotrophin Releasing Factor ◽  
Chronic Anxiety

Treatment of phantom shocks: A case report

2018 ◽  
Vol 54 (3) ◽  
pp. 181-187
Author(s):  
Danielle R Hairston ◽  
Ralph H de Similien ◽  
Seth Himelhoch ◽  
Anique Forrester
Keyword(s):  
Implantable Cardioverter Defibrillator ◽  
Preventive Treatment ◽  
Adverse Outcomes ◽  
Implantable Cardioverter Defibrillators ◽  
Psychological Consequences ◽  
Cardioverter Defibrillator ◽  
Objective Evidence ◽  
Patient Reported ◽  
Life Threatening ◽  
Chronic Anxiety

Implantable cardioverter-defibrillators have become standard preventive treatment for patients with ventricular arrhythmias and other life-threatening cardiac conditions. The advantages and efficiency of the device are supported by multiple clinical trials and outcome studies, leading to its popularity among cardiologists. Implantation of the device is not without adverse outcomes. Implantable cardioverter-defibrillator placement has been found to lead to negative psychological and psychosocial sequelae such as apprehension to engage in physical activity, chronic anxiety, decreased physical and social functioning, a nagging fear of being shocked by the device, and the development of “phantom shocks.” Defined as patient-reported shocks in the absence of evidence that the implantable cardioverter-defibrillator device has discharged, phantom shocks could impact the mental health of those affected. This article reviews the case of Mr. L, a 47-year-old man with ischemic cardiomyopathy who was seen by the psychiatry consultation team while under cardiologic care because he reported that his implantable cardioverter-defibrillator device had been shocking him despite no objective evidence after interrogating the device. A literature review of phantom shocks, their associated symptomatology, and psychological consequences are outlined and discussed.

scholarly journals Epilepsy and anxiety

1993 ◽  
Vol 51 (3) ◽  
pp. 313-318 ◽  
Author(s):  
Marly de Albuquerque ◽  
Carlos José Reis de Campos
Keyword(s):  
Trait Anxiety ◽  
Epileptic Seizures ◽  
Normal Subjects ◽  
Control Group ◽  
Eeg Abnormalities ◽  
Epileptic Patients ◽  
Group A ◽  
State And Trait Anxiety ◽  
Temporal Localization ◽  
Chronic Anxiety

We have analyzed 155 subjects with STAI (State-Trait Anxiety Inventory): 75 epileptic patients and 80 normal subjects used as a control group. A higher trait-anxiety score (chronic anxiety) than that of controls was found for the epileptic group. For the epileptic group higher levels of the A-trait occurred in patients with EEG abnormalities with left temporal localization. We have also observed that the shorter the epilepsy lasts (less than two years), the higher the trait-anxiety levels. Convulsions and awareness loss during epileptic seizures do not modify state and trait-anxiety scores.

scholarly journals Offensive Behavior, Striatal Glutamate Metabolites, and Limbic–Hypothalamic–Pituitary–Adrenal Responses to Stress in Chronic Anxiety

2020 ◽  
Vol 21 (20) ◽  
pp. 7440
Author(s):  
Enrico Ullmann ◽  
George Chrousos ◽  
Seth W. Perry ◽  
Ma-Li Wong ◽  
Julio Licinio ◽  
...  
Keyword(s):  
Plasma Corticosterone ◽  
Behavioral Changes ◽  
Hypothalamic Pituitary Adrenal ◽  
Offensive Behavior ◽  
Response To Stress ◽  
Resistance To Stress ◽  
Chronic Anxiety

Variations in anxiety-related behavior are associated with individual allostatic set-points in chronically stressed rats. Actively offensive rats with the externalizing indicators of sniffling and climbing the stimulus and material tearing during 10 days of predator scent stress had reduced plasma corticosterone, increased striatal glutamate metabolites, and increased adrenal 11-dehydrocorticosterone content compared to passively defensive rats with the internalizing indicators of freezing and grooming, as well as to controls without any behavioral changes. These findings suggest that rats that display active offensive activity in response to stress develop anxiety associated with decreased allostatic set-points and increased resistance to stress.

Sign in / Sign up

Export Citation Format

Share Document